Markers for the Risk of Progression from Mild Cognitive Impairment to Alzheimer's Disease

Journal of Alzheimer's Disease

Volumn 45, Issue 3, 2015, Pages 883-890

  Buratti, Laura ^a   Balestrini, Simona ^a   Altamura, Claudia ^b   Viticchi, Giovanna ^a   Falsetti, Lorenzo ^c   Luzzi, Simona ^a   Provinciali, Leandro ^a   Vernieri, Fabrizio ^b   Silvestrini, Mauro ^a  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^b UNIVERSITY CAMPUS BIO MEDICO   (Italy)

^c Ospedali Riuniti Ancona   (Italy)

Author keywords

Alzheimer's disease; atherosclerosis; carotid arteries; cerebral hemodynamics; mild cognitive impairment; ultrasonography

Indexed keywords

AGED; ALZHEIMER DISEASE; APNEA; ARTERIAL WALL THICKNESS; ARTICLE; BLOOD VESSEL REACTIVITY; BREATH HOLDING; CAROTID ATHEROSCLEROSIS; CEREBROVASCULAR DISEASE; DISEASE COURSE; DISEASE MARKER; ECHOGRAPHY; FEMALE; HEMODYNAMICS; HUMAN; MAJOR CLINICAL STUDY; MALE; MILD COGNITIVE IMPAIRMENT; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; SCORING SYSTEM; SENILE PLAQUE; SENSITIVITY AND SPECIFICITY; COGNITION DISORDERS; COMPLICATION; LONGITUDINAL STUDY; NEUROPSYCHOLOGICAL TEST; PSYCHOLOGY; RECEIVER OPERATING CHARACTERISTIC; STATISTICAL MODEL;

BIOLOGICAL MARKER;

AGED; ALZHEIMER DISEASE; BIOMARKERS; CAROTID INTIMA-MEDIA THICKNESS; CEREBROVASCULAR DISORDERS; COGNITION DISORDERS; DISEASE PROGRESSION; FEMALE; HUMANS; LOGISTIC MODELS; LONGITUDINAL STUDIES; MALE; NEUROPSYCHOLOGICAL TESTS; RISK FACTORS; ROC CURVE;

EID: 84925709066     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-143135     Document Type: Article

References (44)

1. Bennett DA, Wilson RS, Schneider JA, Evans DA, Beckett LA, Aggarwal NT, Barnes LL, Fox JH, Bach J (2002) Natural history of mild cognitive impairment in older persons. Neurology 59, 198-205.
2. Petersen RC (2004) Mild cognitive impairment as a diagnostic entity. J Int Med 256, 183-194.
3. Morris JC, Storandt M, Miller JP, McKeel DW, Price JL, Rubin EH, Berg L (2001) Mild cognitive impairment represents early-stage Alzheimer disease. Arch Neurol 58, 397-405.
4. de la Torre JC (2010) Alzheimer's disease is incurable but preventable. J Alzheimers Dis 20, 861-870.
5. Tsivgoulis G, Alexandrov AV, Wadley VG, Unverzagt FW, Go RC, Moy CS, Kissela B, Howard G (2009) Association of higher diastolic blood pressure levels with cognitive impairment. Neurology 73, 589-595.
6. Viswanathan A, Rocca WA, Tzourio C (2009) Vascular risk factors and dementia: How to move forward? Neurology 72, 368-374.
7. de laTorre JC (2010)Vascular risk factor detection and control may prevent Alzheimer's disease. Ageing Res Rev 9, 218-225.
8. Luzzi S, Vella L, Bartolini M, Provinciali L, Silvestrini M (2010) Atherosclerosis in the evolution of Alzheimer's disease: Can treatment reduce cognitive decline? J Alzheimers Dis 20, 893-901.
9. Risner ME, Saunders AM, Altman JF, Ormandy GC, Craft S, Foley IM, Zvartau-Hind ME, Hosford DA, Roses AD, Rosiglitazone in Alzheimer's Disease Study Group (2006) Efficacy of rosiglitazone in a genetically defined population with mild-to-moderate Alzheimer's disease. Pharmacogenomics J 6, 246-254.
10. de la Torre JC (2010) The vascular hypothesis of Alzheimer's disease: Bench to bedside and beyond. Neurodegener Dis 7, 116-121.
11. Albert MS, DeKosky ST, Dickson D, Dubois B, Feldman HH, Fox NC, Gamst A, Holtzman DM, Jagust WJ, Petersen RC, Snyder PJ, Carrillo MC, Thies B, Phelps CH (2011) The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 7, 270-279.
12. Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E (1999) Mild cognitive impairment: Clinical characterization and outcome. Arch Neurol 56, 303-308.
13. Folstein MF, Folstein SE, McHugh PR (1975) Mini-Mental State: A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12, 189-198.
14. Grigoletto F, Zappala G, Andreson DW, Lebowitz BD (1999) Norms for the Mini-Mental State Examination in a healthy population. Neurology 53, 315-320.
15. Wahlund LO, Barkhof F, Fazekas F, Bronge L, Augustin M, Sjögren M, Wallin A, Ader H, Leys D, Pantoni L, Pasquier F, Erkinjuntti T, Scheltens P, European Task Force on Age-Related White Matter Changes (2001) A new rating scale for age-related white matter changes applicable to MRI and CT. Stroke 32, 1318-1322.
16. th European Stroke Conferences, Mannheim, Germany, 2004, Brussels, Belgium, 2006, and Hamburg, Germany, 2011. Cerebrovasc Dis 34, 290-296.
17. Sutton-Tyrrell K, Lassila HC, Meilahn E, Bunker C, Matthews KA, Kuller LH (1998) Carotid atherosclerosis in premenopausal and postmenopausal women and its association with risk factors measured after menopause. Stroke 29, 1116-1121.
18. Silvestrini M, Cagnetti C, Pasqualetti P, Albanesi C, Altamura C, Lanciotti C, Bartolini M, Mattei F, Provinciali L, Vernieri F (2010) Carotid wall thickness and stroke risk in patients with asymptomatic internal carotid stenosis. Atherosclerosis 210, 452-457.
19. Viticchi G, Falsetti L, Vernieri F, Altamura C, Bartolini M, Luzzi S, Provinciali L, Silvestrini M (2012) Vascular predictors of cognitive decline in patients with mild cognitive impairment. Neurobiol Aging 33, 1127e1-1127e9.
20. Silvestrini M, Altamura C, Cerqua R, Pasqualetti P, Viticchi G, Provinciali L, Paulon L, Vernieri F (2013) Ultrasonographic markers of vascular risk in patients with asymptomatic carotid stenosis. J Cereb Blood Flow Metab 33, 619-624.
21. Silvestrini M, Viticchi G, Falsetti L, Balucani C, Vernieri F, Cerqua R, Luzzi S, Bartolini M, Provinciali L (2011) The role of carotid atherosclerosis in Alzheimer's disease progression. J Alzheimers Dis 25, 719-726.
22. Balucani C, Viticchi G, Falsetti L, Silvestrini M (2012) Cerebral hemodynamics anc cognitive performance in bilateral asymptomatic carotid stenosis. Neurology 79, 1788-1795.
23. Balestrini S, Perozzi C, Altamura C, Vernieri F, Luzzi S, Bartolini M, Provinciali L, Silvestrini M (2013) Severe carotid stenosis and impaired cerebral hemodynamics can influence cognitive deterioration. Neurology 80, 2145-2150.
24. Buratti L, Balucani C, Viticchi G, Falsetti L, Altamura C, Avitabile E, Provinciali L, Vernieri F, Silvestrini M (2014) Cognitive deterioration in bilateral asymptomatic severe carotid stenosis. Stroke 45, 2072-2077.
25. Goldstein LB, Bushnell CD, Adams RJ, Appel LJ, Braun LT, Chaturvedi S, Creager MA, Culebras A, Eckel RH, Hart RG, Hinchey JA, Howard VJ, Jauch EC, Levine SR, Meschia JF, Moore WS, Nixon JV, Pearson TA (2011) American Heart Association Stroke Council; Council on Cardiovascular Nursing; Council on Epidemiology and Prevention; Council for High Blood Pressure Research,; Council on Peripheral Vascular Disease, and Interdisciplinary Council on Quality of Care and Outcomes Research. Guidelines for the primary prevention of stroke: A guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 42, 517-584.
26. McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR Jr, Kawas CH, Klunk WE, Koroshetz WJ, Manly JJ, Mayeux R, Mohs RC, Morris JC, Rossor MN, Scheltens P, Carrillo MC, Thies B, Weintraub S, Phelps CH (2011) The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 7, 263-269.
27. Kleinbaum DG, Kupper LL, Muller KE (2007) Applied regression analysis and other multivariable methods. Duxbury Press, Belmont, CA.
28. Hosmer D, Lemeshow S (1989) Applied logistic regression, Wiley, New York.
29. de la Torre JC (2008) Alzheimer's disease prevalence can be lowered with non-invasive testing. J Alzheimers Dis 14, 353-359.
30. Tsivgoulis G, Katsanos AH, Papageorgiou SG, Dardiotis E, Voumvourakis K, Giannopoulos S (2014) The role of neurosonology in the diagnosis of vascular dementia. J Alzheimers Dis 42(Suppl 3), S251-S257.
31. Silvestrini M, Gobbi B, Pasqualetti P, Bartolini M, Baruffaldi R, Lanciotti C, Cerqua R, Altamura C, Provinciali L, Vernieri F (2009) Carotid atherosclerosis and cognitive decline in patients with Alzheimer's disease. Neurobiol Aging 30, 1177-1183.
32. Safouris A, Hambye AS, Sculier C, Papageorgiou SG, Spyros VN, Gazagnes MD, Tsivgoulis G (2015) Chronic brain hypoperfusion due to multi-vessel extracranial atherosclerotic disease: A potentially reversible cause of cognitive impairment. J Alzheimers Dis 43, 23-27.
33. Sanz C, Andrieu S, Sinclair A, Hanaire H, Vellas B, REAL, Study FR Group (2009) Diabetes is associated with a slower rate of cognitive decline in Alzheimer disease. Neurology 73, 1359-1366.
34. Marshall RS (2012) Effects of altered cerebral hemodynamics on cognitive function. J Alzheimers Dis 32, 633-642.
35. O'Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, Wolfson SK Jr (1999) Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. N Engl J Med 340, 14-22.
36. Tsivgoulis G, Vemmos K, Papamichael C, Spengos K, Manios E, Stamatelopoulos K, Vassilopoulos D, Zakopoulos N (2006) Common carotid artery intima-media thickness and the risk of stroke recurrence. Stroke 37, 1913-1196.
37. Tsivgoulis G, Vemmos K, Papamichael C, Spengos K, Daffertshofer M, Cimboneriu A, Zis V, Lekakis J, Zakopoulos N, Mavrikakis M (2006) Common carotid arterial stiffness and the risk of ischaemic stroke. Eur J Neurol 13, 475-481.
38. Reinhard M, Schwarzer G, Briel M, Altamura C, Palazzo P, King A, Bornstein NM, Petersen N, Motschall E, Hetzel A, Marshall RS, Klijn CJ, Silvestrini M, Markus HS, Vernieri F (2014) Cerebrovascular reactivity predicts stroke in highgrade carotid artery disease. Neurology 83, 1424-1431.
39. Silvestrini M, Pasqualetti P, Baruffaldi R, Bartolini M, Handouk Y, Matteis M, Moffa F, Provinciali L, Vernieri F (2006) Cerebrovascular reactivity and cognitive decline in patients with Alzheimer disease. Stroke 37, 1010-1015.
40. Esh YM, Knebel C, Weiss C, Kalback N, Luehrs W, Childress DC, Beach JL, Weller TG, Kokjohn RO, TA (2003) Cortical and leptomeningeal cerebrovascular amyloid and white matter pathology in Alzheimer's disease. Mol Med 9, 112-122.
41. Iadecola C (2013) The pathobiology of vascular dementia. Neuron 80, 844-866.
42. Defrancesco M, Marksteiner J, Deisenhammer E, Kemmler G, Djurdjevic T, Schocke M (2013) Impact of white matter lesions and cognitive deficits on conversion from mild cognitive impairment to Alzheimer's disease. J Alzheimers Dis 34, 665-672.
43. Tokuchi R, Hishikawa N, Kurata T, Sato K, Kono S, Yamashita T, Deguchi K, Abe K (2014) Clinical and demographic predictors of mild cognitive impairment for converting to Alzheimer's disease and reverting to normal cognition. J Neurol Sci 346, 288-292.
44. Viticchi G, Falsetti L, Vernieri F, Altamura C, Altavilla R, Luzzi S, Bartolini M, Provinciali L, Silvestrini M (2014) Apolipoprotein E genotype and cerebrovascular alterations can influence conversion to dementia in patients with mild cognitive impairment. J Alzheimers Dis 41, 401-410.